LIXIANA

This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Turkey, United Kingdom

Active ingredients

The drug LIXIANA contains one active pharmaceutical ingredient (API):

1 Edoxaban UNII 32W99UE810 - EDOXABAN TOSYLATE

Edoxaban is a highly selective, direct and reversible inhibitor of factor Xa, the serine protease located in the final common pathway of the coagulation cascade. Edoxaban inhibits free factor Xa, and prothrombinase activity. Inhibition of factor Xa in the coagulation cascade reduces thrombin generation, prolongs clotting time and reduces the risk of thrombus formation. Read about Edoxaban

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LIXIANA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AF03		B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AF Direct factor Xa inhibitors
Discover more medicines within B01AF03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 530418060015302, 530418060015402, 530418060015502, 530418060015602, 530418060015702
Country: CA	Health Products and Food Branch	Identifier(s): 02458640, 02458659, 02458667
Country: EE	Ravimiamet	Identifier(s): 1691502, 1691513, 1691524, 1691535, 1691546, 1691557, 1691568, 1691579, 1691580, 1691591, 1691603, 1691614, 1691625, 1691636, 1691647, 1691658, 1691669, 1691670, 1691681, 1691692, 1691704, 1691715, 1691726
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 115993001, 115993005, 115993015, 115993018, 115993028
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 056500, 078145, 080621, 408102, 579911
Country: FR	Base de données publique des médicaments	Identifier(s): 60202483, 65449516, 66261727
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 299022, 299025, 299028
Country: HK	Department of Health Drug Office	Identifier(s): 64525, 64526, 64527
Country: IE	Health Products Regulatory Authority	Identifier(s): 36930, 36931, 36932
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8518, 8519, 8520
Country: IT	Agenzia del Farmaco	Identifier(s): 044315012, 044315024, 044315036, 044315048, 044315051, 044315063, 044315075, 044315087, 044315099, 044315101, 044315113, 044315125, 044315137, 044315149, 044315152, 044315164, 044315176, 044315188, 044315190, 044315202, 044315214, 044315226, 044315238, 044315240, 044315253, 044315265, 044315277, 044315289, 044315291, 044315303
Country: JP	医薬品医療機器総合機構	Identifier(s): 3339002F1020, 3339002F2026, 3339002F3022, 3339002F4029, 3339002F5025, 3339002F6021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1076911, 1076912, 1076913, 1076914, 1076915, 1076916, 1076917, 1076918, 1076919, 1076920, 1076921, 1076922, 1076923, 1076924, 1076925, 1076926, 1076927, 1076928, 1076929, 1076930, 1076931, 1076932, 1076933, 1076934, 1076935, 1076936, 1076937, 1076938, 1091745, 1091746
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 128171, 128198, 128201
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100349219, 100349254, 100349260
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699228090768, 8699228090775, 8699228090782